A case of Mycobacterium tuberculosis laboratory cross-contamination.


Journal

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
ISSN: 1437-7780
Titre abrégé: J Infect Chemother
Pays: Netherlands
ID NLM: 9608375

Informations de publication

Date de publication:
Aug 2019
Historique:
received: 01 02 2019
revised: 08 03 2019
accepted: 13 03 2019
pubmed: 16 4 2019
medline: 18 12 2019
entrez: 16 4 2019
Statut: ppublish

Résumé

A laboratory cross-contamination event was suspected because Mycobacterium tuberculosis was unexpectedly detected at a high incidence in the cultures of several clinical specimens at the National Hospital Organization, Tokyo National Hospital, Japan. To describe a case of Mycobacterium tuberculosis laboratory cross-contamination. We reviewed the medical records of 20 patients whose clinical specimens were suspected to have been contaminated by Mycobacterium tuberculosis. Variable number of tandem repeat analysis with 15 loci, the Japan Anti-Tuberculosis Association-12, and three additional hyper-variable loci, was performed to identify the cross-contamination event. The clinical, laboratory, and variable number of tandem repeat data revealed that the cross-contamination had possibly originated from one strongly positive specimen, resulting in false-positive results in 11 other specimens, including a case treated with anti-tuberculosis drugs. Clinical and laboratory data must be re-evaluated when cross-contamination is suspected and variable number of tandem repeat analysis should be used to confirm cross-contamination. Furthermore, original isolates should be stored appropriately, without sub-culturing and genotyping should be performed at the earliest possible for better utilization of variable number of tandem repeat for the identification of cross-contamination.

Identifiants

pubmed: 30982725
pii: S1341-321X(19)30076-5
doi: 10.1016/j.jiac.2019.03.012
pii:
doi:

Substances chimiques

DNA, Bacterial 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

610-614

Informations de copyright

Copyright © 2019 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Auteurs

Keita Takeda (K)

Department of Mycobacterium Reference and Research, The Research Institute of Tuberculosis, Japan; Center for Pulmonary Diseases, National Hospital Organization Tokyo National Hospital, Japan; Department of Basic Mycobacteriology, Graduate School of Biomedical Science, Nagasaki University, Japan. Electronic address: takedak@tokyo-hosp.jp.

Yoshiro Murase (Y)

Department of Mycobacterium Reference and Research, The Research Institute of Tuberculosis, Japan. Electronic address: ymurase@jata.or.jp.

Masahiro Kawashima (M)

Center for Pulmonary Diseases, National Hospital Organization Tokyo National Hospital, Japan. Electronic address: mkawashima-in@tokyo-hosp.jp.

Maho Suzukawa (M)

Clinical Research Center, National Hospital Organization Tokyo National Hospital, Japan. Electronic address: suzukawam@tokyo-hosp.jp.

Junko Suzuki (J)

Center for Pulmonary Diseases, National Hospital Organization Tokyo National Hospital, Japan. Electronic address: junkosz-in@tokyo-hosp.jp.

Akira Yamane (A)

Center for Pulmonary Diseases, National Hospital Organization Tokyo National Hospital, Japan. Electronic address: yamanea@tokyo-hosp.jp.

Yuriko Igarashi (Y)

Department of Mycobacterium Reference and Research, The Research Institute of Tuberculosis, Japan. Electronic address: igarashi@jata.or.jp.

Kinuyo Chikamatsu (K)

Department of Mycobacterium Reference and Research, The Research Institute of Tuberculosis, Japan. Electronic address: chikamatsu@jata.or.jp.

Yuta Morishige (Y)

Department of Mycobacterium Reference and Research, The Research Institute of Tuberculosis, Japan. Electronic address: ymorishige@jata.or.jp.

Akio Aono (A)

Department of Mycobacterium Reference and Research, The Research Institute of Tuberculosis, Japan. Electronic address: a.aono1967@gmail.com.

Hiroyuki Yamada (H)

Department of Mycobacterium Reference and Research, The Research Institute of Tuberculosis, Japan. Electronic address: hyamada@jata.or.jp.

Akiko Takaki (A)

Department of Mycobacterium Reference and Research, The Research Institute of Tuberculosis, Japan. Electronic address: takaki@jata.or.jp.

Atsuhisa Tamura (A)

Center for Pulmonary Diseases, National Hospital Organization Tokyo National Hospital, Japan. Electronic address: tamura-in@tokyo-hosp.jp.

Hideaki Nagai (H)

Center for Pulmonary Diseases, National Hospital Organization Tokyo National Hospital, Japan. Electronic address: hnagai-tokyohosp@umin.ac.jp.

Hirotoshi Matsui (H)

Center for Pulmonary Diseases, National Hospital Organization Tokyo National Hospital, Japan. Electronic address: matsui.hirotoshi.sa@mail.hosp.go.jp.

Shigeto Tohma (S)

Asthma, Allergy and Rheumatology Center, National Hospital Organization Tokyo National Hospital, Japan. Electronic address: touma-shigeto@tokyo-hosp.jp.

Satoshi Mitarai (S)

Department of Mycobacterium Reference and Research, The Research Institute of Tuberculosis, Japan; Department of Basic Mycobacteriology, Graduate School of Biomedical Science, Nagasaki University, Japan. Electronic address: mitarai@jata.or.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH